Akero Therapeutics, Inc. (AKRO)
54.65
0.00 (0.00%)
USD |
NASDAQ |
Dec 18, 16:00
Akero Therapeutics Accounts Payable (Quarterly): 20.40M for Sept. 30, 2025
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Pfizer Inc. | 5.024B |
| Eli Lilly & Co. | 4.262B |
| Bristol Myers Squibb Co. | 4.288B |
| Johnson & Johnson | 9.625B |
| Adaptive Biotechnologies Corp. | 10.27M |